Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB). [electronic resource]
Producer: 20140116Description: 208-15 p. digitalISSN:- 1423-0232
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Transitional Cell -- drug therapy
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Prospective Studies
- Survival Analysis
- Taxoids -- administration & dosage
- Treatment Outcome
- Urinary Bladder Neoplasms -- drug therapy
- Urothelium -- pathology
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.